“Treatment”的搜索结果，显示 351-360 项，共有 18185 项
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...
... treatment, in order to classify patients into post-consolidation treatment groups. On the second part of this study, patients will receive the remainder of ...
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...
... treatment of B cell malignancies by engineering T cells to recognize B ... treatment delivered as a sequence of treatments approximately 30-90 days apart.
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies. Rochester, Minn. The purpose of this study is to find out ...
Similar to other types of lymphoma, PTCL undergoes specific DNA changes that help it hide from the immune system. Treatment depends on the PTCL subtype and may ...
When surgery risks harming nearby nerves, you may have other treatments. Because most nerve sheath tumors are benign, staging is not needed. Malignant tumors ...
Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used. Fertility outcomes in ...
Treatment Resistant Depression Subcallosal Cingulate Network. Rochester, Minn ... treatment of non-psychotic unipolar Major Depression Disorder (MDD) ...
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。